Download The University of Oklahoma Health Sciences Center

The University of Oklahoma Health Sciences Center
Occupational Safety and Health Requirements
Federal Occupational Safety and Health Administration (OSHA), Environmental Protection Agency
(EPA), Oklahoma Department of Environmental Quality (ODEQ), and Oklahoma Department of
Labor (ODOL) safety, health, and environmental regulations apply to residents, the facilities in which
they perform rotations, and the University of Oklahoma Health Sciences Center (OUHSC). In order
to comply with these regulations, the following training program is required annually.
HAZARD COMMUNICATION
The Hazard Communication Standard applies to hazardous chemicals (those that are health
hazards or physical hazards) in the workplace. The concept of the Hazard Communication
Standard is to ensure that workers are informed about the hazards associated with the materials
with which they are working. For example, information about some hazardous chemicals found in a
healthcare environment is as follows.
 Isopropyl alcohol is a widely used antiseptic and disinfectant. Isopropyl alcohol is
flammable and can cause irritation of the eyes and mucous membranes. Contact with the
liquid may also cause skin rashes. Workers should wear appropriate protective equipment
such as gloves and face shields to prevent repeated or prolonged skin contact with
isopropyl alcohol.
 Sodium hypochlorite (chlorine bleach) is used for disinfecting work surfaces.
Chlorine-containing cleaning materials should never be mixed with ammonia or
ammonia-containing materials because the reaction may produce a toxic gas. Repeated
exposure to chlorine may cause a runny nose, coughing, wheezing, and other respiratory
problems. Mild irritation of the mucous membranes can occur at low airborne exposure
concentrations. Workers should wear gloves to prevent skin contact and splash-proof
safety goggles where there is any possibility that chlorine-containing solutions may contact
the eyes.
 Phenolics are used as disinfectants. Serious health effects may follow exposure to
phenol through skin adsorption, inhalation, or ingestion including local tissue irritation and
necrosis, loss of skin pigment, severe burns of the eyes and skin, irregular pulse,
stertorous breathing, darkened urine, convulsions, coma, collapse, and death. W orkers
should wear gloves, face shields, splash-proof safety goggles, and other appropriate
protective clothing necessary to prevent any possibility of skin or eye contact with solid or
liquid phenol or liquids containing phenol. Contaminated clothing should be changed
immediately and skin that becomes contaminated with phenol should be immediately
washed with soap or mild detergent and rinsed with water.
 Gluteraldehyde is used for cold sterilization of instruments. Gluteraldehyde may be
absorbed into the body by inhalation, ingestion, and skin contact. Extensive skin contact
may cause allergic eczema and may also affect the nervous system. Gluteraldehyde can
cause eye, throat, and lung irritation; cough; chest tightness; headache; skin irritation; and
asthma-like symptoms. Gluteraldehyde exposure has been associated with fetotoxicity in
mice, DNA damage in chickens and hamsters, and mutagenicity in microorganisms.
Workers should avoid breathing gluteraldehyde vapors and should wear protective
clothing such as gloves and eye protection where there is any possibility of skin or eye
contact with gluteraldehyde. Skin that becomes contaminated with gluteraldehyde should
Occupational Safety and Health Requirements
4/10
Page 1
be washed immediately.
 Antineoplastic drugs derive their name from the fact that they interfere with or prevent
the growth and development of malignant cells and neoplasms. They may also be called
cytotoxic or cytostatic because they have the ability to prevent the growth and proliferation
of cells. Cytotoxic/antineoplastic drugs have been reported to cause mutations in test
systems and are carcinogenic and teratogenic in animals and thus can be considered to
be potential human carcinogens (e.g., cyclophosphamide, chlorambucil). The acute
effects of accidental exposure to these drugs can be severe. For example, an accidental
needle prick of a patient=s finger with mitomycin-C has been reported to cause the
eventual loss of function of that hand. Some antineoplastic drugs (e.g., mustine
hydrochloride, doxorubicin) are strong vesicants that can cause varying degrees of local
tissue necrosis upon direct contact. Specialized training in proper work practices and
protective equipment is required when working with these drugs.
The major requirements of the regulation include annual training for all employees working with any
hazardous chemical, ensuring that containers of hazardous substances are properly labeled as to
the hazard, and that material safety data sheets (MSDSs) are readily available for all hazardous
materials used or stored in the work place. MSDSs are required by law to be provided by
manufacturers or vendors of products containing hazardous materials, and include information such
as chemical composition, exposure limits, potential health effects, first aid procedures, personal
protective equipment requirements, and spill/leak procedures. MSDSs are available through the
internet - links have been identified by the OUHSC Environmental Health and Safety Office (EHSO)
at http://www.ouhsc.edu/ehso/local/Msds1.htm.
If you have any questions about the hazard of any product, disinfectant, hazardous drug, or other
agent, consult the label, the MSDS, the EHSO at 405/271-3000, or the rotation facility's safety office.
BLOODBORNE PATHOGENS
Bloodborne pathogens are infectious microorganisms carried in human blood that can cause
serious disease and include the human immunodeficiency virus (HIV), hepatitis B virus (HBV),
hepatitis C virus (HCV), Plasmodium sp. (the agent which causes malaria), Treponema pallidum (the
agent which causes syphilis), and other infectious agents. Transmission of these infectious
diseases can occur through sexual contact and contact with blood and other potentially infectious
body fluids, including occupational exposures such as needlesticks or body fluid splashes to the
eyes, nose, throat, an open cut, scratch, skin abrasion, dermatitis, or acne.
Some pertinent facts about bloodborne pathogens are as follows.
 As of December, 2006, at least 57 healthcare workers have been documented to
seroconvert to HIV after occupational exposure to HIV-infected blood, including 19
laboratory workers. 140 additional cases of HIV infection or AIDS are reported in
healthcare workers without such documentation, but no other risk factors other than
occupational exposure are reported.
 A total of 1,407 physicians and 92 surgeons have died from AIDS.
 Up to 800,000 percutaneous injuries may occur annually among all U.S. health care
workers (both hospital-based workers and those in other health care settings). After
percutaneous injury with a contaminated sharp instrument, the average risk of infection is
0.3% for HIV and ranges from 6% to 30% for hepatitis B.
Occupational Safety and Health Requirements
4/10
Page 2
 From 1993 – 1999, on average, 400 healthcare workers were infected with hepatitis B
each year.
 Hepatitis B infects approximately 73,000 people in the United States each year, however
the number of chronically infected Americans is about 1.25 million. Only approximately
70% are symptomatic. Those with symptoms range from mild fever and nausea to severe
abdominal pain, jaundice, and liver failure.
 Approximately 3.9 million Americans have been infected with hepatitis C virus (HCV).
While 80% of persons infected with HCV have no symptoms, approximately 75-85%
become chronically infected and chronic liver disease occurs in greater than 70% of
persons chronically infected.
 While an effective vaccine and post-exposure prophylaxis is available to prevent hepatitis
B, no vaccine is available to prevent hepatitis C and no post-hepatitis C exposure
immunoprophylaxis has been successfully developed. According to the CDC, antiviral
drugs, such as interferon used alone or in combination with ribavirin, have been approved
for the treatment of persons with chronic hepatitis C. Interferon is effective in 10 to 20
persons out of 100 treated. Combination therapy is effective in up to 5 out of 10 persons.
AUniversal precautions@ must be used when exposure to human blood/blood products or other
potentially infectious materials may occur. Other potentially infectious material means the following:






semen
 vaginal secretions
pericardial fluid
 cerebrospinal fluid
synovial fluid
 pleural fluid
peritoneal fluid
 amniotic fluid
saliva in dental procedures
any body fluid that is visibly contaminated with blood or where it is difficult or impossible to
differentiate between body fluids
 any unfixed tissue or organ (other than intact skin) from a human, living or dead, including
human cell lines and human cell strains
 cell or tissue cultures, organ cultures, culture medium or other solutions known to contain
bloodborne pathogens
 blood, organs, or other tissues from experimental animals only if infected with HIV, HBV or
other bloodborne pathogens infectious to man
Under “universal precautions”, the blood and above listed body fluids of all persons, regardless
of age or background, should be treated as infectious for HBV, HIV, and other bloodborne
pathogens. OSHA does not regulate exposure to urine, feces, or vomitus under the universal
precautions requirements in the bloodborne pathogen standard. However, hospital procedures, and
the OUHSC Infectious Diseases Policy require the additional use of Astandard precautions@ which
apply to 1) blood; 2) all body fluids, secretions, and excretions except sweat, regardless of whether
or not they contain visible blood; 3) nonintact skin; and 4) mucous membranes. OSHA also does
not regulate exposure to animal blood or tissue, unless it is known to be infected with a bloodborne
pathogen infectious to man.
Universal precautions involve the use of personal protective equipment (PPE) such as gloves,
gowns, aprons, masks, or protective eyewear to reduce the risk of exposure of the health care
worker's skin or mucous membranes to potentially infectious materials.
 Gloves should be worn when there is reasonable anticipation of hand contact with human
Occupational Safety and Health Requirements
4/10
Page 3
blood or other potentially infectious materials, mucous membranes, and non-intact skin
such as during phlebotomies and when handling or touching contaminated items. (Use
powder-free gloves with reduced protein content to minimize latex exposure;
hypoallergenic latex gloves do not reduce the risk of latex allergy but may reduce reactions
to chemical additives in the latex. When wearing latex gloves, do not use petroleumbased products, which will destroy the integrity of the glove.
 Masks in combination with eye protection such as goggles or face shields should be
worn whenever splashes, spray, spatter, or droplets of blood or other potentially infectious
material may be generated and eye, nose, or mouth contamination can be reasonably
anticipated.
 Gowns, aprons, lab coats, surgical caps or hoods, and/or shoe covers should be
worn when gross contamination can be reasonably anticipated.
PPE should be removed as soon as possible if contaminated by blood or other potentially infectious
material. Gloves should be removed and replaced when contaminated, torn, before touching
objects such as door knobs, light switches, telephones, etc., and should not be reused. Hands
should be washed after removing gloves; use a mild soap and dry thoroughly to minimize dermatitis.
Contaminated PPE should be placed in a designated container labeled with the biohazard symbol.
Contaminated sharps should be placed in a biohazard labeled puncture-proof sharps container.
Untreated biomedical waste may not be disposed of in the regular trash, but should be placed in a
red or biohazard-labeled bag or box.
The hepatitis B vaccination series is highly recommended (but not mandatory) for employees and
students with occupational exposure to blood or other potentially infectious materials. OUHSC
employees with no such potential exposure are not eligible for the vaccination unless they pay for it
themselves. Those eligible may decline the vaccination and request it at a later date if a change of
mind occurs. The vaccination series consists of 3 shots followed by a titer. Although some people
may lose detectable antibodies over time, immunologic memory still persists. Therefore, the CDC
does not recommend booster doses unless an exposure occurs, at which time a titer will be
performed to determine need.
Needlesticks, other percutaneous injuries, and splashes to mucous membranes are a major
concern for all health care workers. Safer needle devices should be used wherever possible.
Used sharps should be placed in a closely positioned sharps container immediately. Should an
exposure occur, report the incident to your Program Director, call OUHSC Employee Health at
405/271-3100, and proceed to medical attention as soon as possible. Current studies indicate that
for some exposures, medical treatment provided within the first 1-2 hours of exposure has been
effective in the prevention of the spread of bloodborne diseases (still go for treatment even if you
miss that 1-2 hour window). Make note of the brand and type of device (if applicable) which
caused the injury and report it on the appropriate injury reporting forms, as OSHA now
requires that such information be tracked.
TUBERCULOSIS
Tuberculosis (TB) is the clinical illness caused by the bacterium M. tuberculosis. M. tuberculosis is
spread through airborne particles (droplet nuclei) generated when persons with TB sneeze, cough,
speak, or sing. These particles are an estimated 1-5 μm in size. Normal air currents can keep them
airborne for prolonged time periods and spread them throughout a room or building. Infection may
occur when a susceptible person inhales droplet nuclei containing TB bacilli, and these bacilli
Occupational Safety and Health Requirements
4/10
Page 4
become established in the alveoli of the lungs and spread throughout the body. The probability that
a susceptible person will become infected is dependent on the concentration of infectious droplet
nuclei in the air.
If infection occurs, in about 90% of the cases in the U.S., the body's immunologic response usually
limits further multiplication and spread within approximately two to ten weeks after initial infection this results in what is called latent TB. Persons with latent TB will have a positive skin test but will
have no symptoms and will not be contagious. Of the remaining 10%, about 5% will develop active
TB disease (will have symptoms and will be contagious) in the first year or two after infection and
another 5% will develop disease later in life.
While TB has been successfully treated with antitubercular drugs for years, new strains of drugresistant TB are appearing, including multidrug-resistant strains, which have a 50-80% mortality rate.
Drug-resistant TB is prevalent in TB patients who don't comply with treatment. These patients may
not complete the minimum six month period of medication because the treatment regimen is too
strict, they believe the side effects are too harsh, or the symptoms clear up and they don't believe
they need to complete the medication.
An important aspect of infection control is prompt recognition of patients with active TB. Since
clinical confirmation through laboratory testing takes several days or weeks, patients must be
assumed to have active TB if they are exhibiting the signs and symptoms of active TB which include:
 a cough for more than three weeks, or
 a cough of any duration, plus coughing up blood, weight loss, night sweats or fever.
Immediately after determining that a patient may have active TB, the patient should be given a
surgical mask, instructed to keep it on, and be placed in a TB isolation room. Patients placed in
isolation should remain in their isolation rooms with the door closed. If possible, diagnostic and
treatment procedures should be performed in the isolation rooms to avoid transporting patients
through other areas of the facility. The number of persons entering an isolation room should be
minimal, and all persons who enter an isolation room should wear an N-95 respirator, not a surgical
mask (see Respiratory Protection, below).
All OUHSC employees with patient contact must participate in the skin testing program. The
Mantoux Purified Protein Derivative (PPD) skin test should be performed by Employee Health upon
entry into the skin testing program and at least annually thereafter, unless contraindicated or a
negative skin test, chest x-ray or physician’s statement indicating a non-infectious condition within
the last two months can be documented. The skin test involves the placement of PPD tuberculin
just beneath the surface of the skin of the forearm, with results read within 48 to 72 hours. The PPD
test is contraindicated only for persons who have had a severe reaction (e.g., necrosis, blistering,
anaphylactic shock, or ulcerations) to a previous PPD or who have been vaccinated with Bacillus
Calmette-Guérin (BCG). It is not contraindicated for any other persons, including infants, children,
pregnant women, persons who are HIV-infected. Persons who have been vaccinated with BCG
should have their blood drawn for an Interferon Gamma Release Assay (IGRA) tuberculin test
instead of a skin test. Persons with documented past positive skin test results (persons with latent
TB) should also participate and be evaluated by the health care provider, but will not be required to
have a skin test.
RESPIRATORY PROTECTION
CDC and OSHA recommend the use of respirators when caring for persons with known, probable or
Occupational Safety and Health Requirements
4/10
Page 5
suspected H1N1 or influenza-like illness, TB, SARS, and other airborne illnesses. Respirator, in this
case, refers to an N-95 or higher filtering face piece respirator certified by the CDC’s National
Institute for Occupational Safety and Health (NIOSH).
There are important differences between surgical masks (facemasks) and respirators. Respirators
are designed to reduce an individual's exposure to airborne contaminants. A respirator that fits
snugly on the face can filter out virus or bacteria-containing small particle aerosols that can be
generated by an infected person (e.g., from coughs and sneezes), but, compared with a facemask, it
is harder to breathe through a respirator for long periods of time. In comparison, surgical masks
are not designed to prevent inhalation of airborne contaminants. Facemasks do not seal tightly
to the face and are used to block large droplets from coming into contact with the wearer’s mouth or
nose. They are not designed to protect against breathing in very small particle aerosols that may
contain viruses. Facemasks help stop droplets from being spread by the person wearing them.
In the occupational healthcare setting, respiratory protection is recommended when healthcare
or other workers are in close contact (i.e. being within about 6 feet) with persons with TB, SARS or
an influenza-like illness and when entering a room where such a patient is housed. Facemasks
should be worn by patients exhibiting symptoms of TB, SARS, and influenza-like illnesses.
To wear a respirator, OSHA requires that employees be fit tested, medically evaluated and trained.
OSHA does not allow tight-fitting respirators to be used by people with facial hair that interferes with
the face seal. An appropriate fit cannot be maintained if facial hair is present in the area where
the respirator fits to the face. Persons who cannot achieve a fit for the respirators supplied by the
facility or who have facial hair which interferes with the face-to-facepiece seal of the respirator
should not see patients with known or suspected TB unless they utilize positive pressure HEPAfiltered hooded respirators.
It is important to note that a physiological burden is imposed on a respirator user. The fear of tight
or enclosed spaces, pulmonary or cardiovascular symptoms or problems, eye irritation, nose, throat,
or skin problems, vision or hearing problems, and musculoskeletal problems are indicative that the
ability of an employee to use some types of respiratory protection equipment may be compromised.
Therefore, a medical evaluation is necessary prior to wearing a respirator. To begin the medical
evaluation process, the employee must complete the OSHA Respirator Medical Evaluation
Questionnaire (Mandatory) from 29 CFR 1910.134, Appendix C form and submit it to OUHSC
Employee Health for evaluation.
N-95 disposable respirators will only protect against airborne dusts, mists and particles and will not
protect against other contaminants such as organic solvent vapors or other chemical hazards. N-95
respirators are not for use in atmospheres containing less than 19.5 percent oxygen.
Respirators will only provide the protection needed if they fit the face properly. To properly don an
N-95 respirator, follow the appropriate instructions.
Kimberly-Clark Tecnol PFR95 N95 Particulate Respirator
 Separate the edges of the respirator to fully open it.
 Slightly bend the nose wire to form a gentle curve.
 Hold the respirator upside down to expose the two headbands.
 Using your index fingers and thumbs, separate the two headbands.
 While holding the headbands with your index fingers and thumbs, cup the respirator under
Occupational Safety and Health Requirements
4/10
Page 6
your chin (orange side out).
 Pull the headbands up over your head (at the same time).
 Release the lower headband from your thumbs and position it at the base of your neck.
 Position the remaining (top) headband on the crown of your head.
 Conform the nosepiece across the bridge of your nose by firmly pressing down with your
fingers. Continue to adjust the respirator and secure edges until you feel you have
achieved a good facial fit. Now perform a Fit Check (see below).
Note: Do not pinch! Pinching the nosepiece may result in improper fit and less effective
respirator performance. Use two hands to gently mold the metal nose clip around the nose.
Moldex 2200 N-95 Particulate Respirator
 Hold respirator in hand with molded nose contour (narrow end) at finger tips, allowing
headstraps to fall below the hand.
 Place respirator under chin with molded nose contour (narrow end) up. Cushion must be
uncreased inside respirator.
 Raise top strap to top back of head.
 Pull shorter bottom strap over head, below ears, to around neck. Do not wear with only
one strap.
Head coverings, goggles or glasses must be worn on the outside of the respirator straps so that
nothing passes between the respirator sealing surface and the face.
A “fit check” must be performed every time you put the respirator on to be sure it is seated
properly. To do this for the Moldex type, cover front of respirator by cupping both hands and inhale
sharply. A negative pressure should be felt inside the respirator. To do this for the Kimberly Clark
Tecnol type, the wearer should forcefully inhale and exhale several times. The respirator should
collapse slightly upon inhaling and expand upon exhaling. Observe for air leaks around the bridge of
the nose and edges of the respirator. Re-adjust the respirator until a face seal is obtained. If a
proper fit cannot be achieved, do not enter a contaminated area.
A qualitative “fit test” (different from the fit check) is required annually to verify that the respirator fits
appropriately and does not leak. This is done by aerosolizing a saccharin solution around the
respirator while a series of movements occur. If the person being tested detects the sweetness of
the saccharin solution, a fit has not been achieved. If the respirator cannot be adjusted sufficiently
to achieve an appropriate fit, another size or model should be attempted.
Respirators should be discarded if the respirator becomes damaged, difficult to breathe through,
contaminated or wet. If a respirator will be reused, it should be stored in a clean and sanitary
location. Respirators should not be modified, folded or put in an abnormal shape that may impair
the respirator’s function. Sharing a disposable respirator is not acceptable.
HAND HYGIENE
Hand hygiene is the simplest, most effective measure for preventing nosocomial infections. CDC
recommendations for hand hygiene practices for personnel with patient care responsibilities include
the following.
Occupational Safety and Health Requirements
4/10
Page 7
 Wash hands with either a non-antimicrobial soap and water or an antimicrobial soap and
water (alcohol-based hand rubs are not acceptable under these conditions):





when hands are visibly dirty;
when hands are contaminated with proteinaceous material;
when hands are visibly soiled with blood or other body fluids;
if exposure to Bacillus anthracis or Clostridium difficile is suspected or proven; and
before eating and after using a restroom
 If hands are not visibly soiled, use an alcohol-based hand rub or wash hands with an
antimicrobial soap and water for routinely decontaminating hands in the following clinical
situations:








before having direct contact with patients;
before donning sterile gloves when inserting a central intravascular catheter;
before inserting indwelling urinary catheters, peripheral vascular catheters, or other
invasive devices that do not require a surgical procedure;
after contact with a patient's intact skin (e.g., when taking a pulse or blood pressure,
and lifting a patient);
after contact with body fluids or excretions, mucous membranes, nonintact skin, and
wound dressings only if hands are not visibly soiled;
if moving from a contaminated-body site to a clean-body site during patient care;
after contact with inanimate objects (including medical equipment) in the immediate
vicinity of the patient; and
after removing intact gloves.
All personnel with patient care responsibilities should wear gloves for all hand-contaminating
activities.
Employees with patient care responsibilities are prohibited by University and Hospital
policies from wearing artificial nails (anything applied to natural nails other than nail polish is
considered artificial, including bonding, tips, wrappings, tapes, and inlays). Nail polish, if
chipped or worn, should be removed. Natural nails should be maintained less than one quarter of
an inch long if personnel care for patients at high risk of acquiring infections (e.g. patients in
intensive care units or in transplant units).
OTHER INFECTIOUS DISEASES ISSUES
OUHSC faculty, students and staff with patient care responsibilities may not refuse to treat a patient
whose condition is within their realm of competence solely because the patient has an infectious
disease. However, departments/clinics may choose to defer non-emergency procedures on patients
with airborne infectious diseases until such time as the patient is non-infectious.
All patient medical records must be kept confidential and must not be disclosed to others except as
required or permitted by the Health Insurance Portability and Accountability Act of 1996 (HIPAA)
privacy regulations and other applicable laws or as authorized in writing by the patient. Oklahoma
law specifically requires the good faith disclosure of infectious disease test results to the Oklahoma
State Department of Health and to healthcare personnel having a reasonable need to know about
the infection for purposes of providing patient care.
All existing and new employees are required to complete the Vaccine History Form for OUHSC/OUOccupational Safety and Health Requirements
4/10
Page 8
Tulsa Employees and Students. Proof of immunity to measles, mumps, rubella, and varicella must
be documented for all residents. Residents who do not show proof of previous vaccination/immunity
(or for varicella, have a documented history of chicken pox) of these diseases shall be titered for
immunity and/or be offered the vaccination at no cost to the employee. Residents who lack
documented immunity and who are subsequently exposed shall be quarantined for the incubation
period of the exposure on available leave with pay if available, and if not available, leave without
pay.
FIRE SAFETY
Flammable materials must be properly stored, minimum aisle width must be maintained in hallways
and exits, exits must not be blocked, and fire doors must not be propped open. Fire extinguishers
are provided throughout most healthcare facilities. Look around your work area BEFORE an
emergency and familiarize yourself with the following:
 where the fire alarm pull stations are located
 where the exit routes are located
 where the fire extinguishers are located
In addition, it is important to remember to not use elevators in the event of a fire. Elevator shafts act
like chimneys and will fill with smoke easily. In addition, the elevators will likely shut down in the
event of a fire.
If a small fire occurs, immediately call or have someone call the appropriate emergency number for
the facility you are in (for OUHSC facilities, call OUHSC Police at 271-4911. To use the fire
extinguisher, remember the acronym PASS:
 Pull the pin
 Aim the discharge toward the base of the flames (do not aim the fire extinguisher directly
onto the source as it may spread the flames, and begin discharging the extinguisher 8-10
feet away from the fire source)
 Squeeze the handle
 Sweep from side to side
If the fire is too large to handle, pull the handle on the nearest fire alarm pull station, evacuate the
building, and call 1-4911 at OUHSC/OU Medical Center or the facility's emergency number.
EXPOSURE OR INJURY PROCEDURES
If a resident sustains an exposure to potentially infectious material (such as a stick with a
contaminated needle or a splash of potentially infectious material in the eye, mouth, mucous
membrane, or non-intact skin), immediately clean the wound with soap and water; flush mucous
membranes with water or normal saline solution. Immediately after wound care, notify your Program
Director, call OUHSC Employee Health at 405/271-3100, and proceed for medical treatment within
1-2 hours if possible (still proceed for treatment if you miss this 1-2 hour window).
During the hours of 8:30 a.m. to 4:30 p.m., Monday - Friday, residents exposed to potentially
infectious or hazardous materials or otherwise injured while on the job should report for evaluation
and treatment to Employee Health located at Family Medicine Clinic, 900 N.E. 10th St., Green Clinic,
Occupational Safety and Health Requirements
4/10
Page 9
Oklahoma City, OK 73104 (405/271-3100). Residents experiencing exposures after-hours should
report for treatment to the emergency room of the facility in which they are working. Do not seek
treatment at the facility's employee health department. Call OUHSC Employee Health on the next
business day to report your exposure.
All work-related illness, injuries, or exposures should be reported as soon as possible to the
Program Director or his/her office for verification. Failure to document a work-related
injury/illness/exposure may result in the denial of the claim and/or delay of payment for medical
services. For forms, go to: http://hr.ou.edu/benefits/Workerscompensation.asp.
Occupational Safety and Health Requirements
4/10
Page 10